Screening for Cancer in Patients with Glomerular Diseases.
Clin J Am Soc Nephrol
; 15(6): 886-888, 2020 06 08.
Article
in En
| MEDLINE
| ID: mdl-32019761
Key words
Cancer; cost-benefit analysis; cytosolic phospholipases A2; early detection of cancer; follow-up studies; human PLA2R1 protein; humans; immunosuppressive agents; kidney; membranoproliferative glomerulonephritis; membranous nephropathy; neoplasms; nephrologists; nephrology; nephrotic syndrome; phospholipase A2 receptors; phospholipases A2; recurrence; risk factors; thrombospondins; treatment failure
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glomerulonephritis, Membranous
/
Early Detection of Cancer
/
Neoplasms
/
Nephrotic Syndrome
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Language:
En
Journal:
Clin J Am Soc Nephrol
Journal subject:
NEFROLOGIA
Year:
2020
Document type:
Article
Affiliation country:
Francia